Ketamine Infusion Therapy for PTSD – Results of an Important New Study
A recent study[1] published in the January 5, 2021 American Journal of Psychiatry by Dr. Adriana Feder and her team at the Icahn School of Medicine at Mt. Sinai was the first randomized, double blind, placebo-controlled trial of repeated ketamine infusions for chronic PTSD. 67% of those in the ketamine group responded after 6 infusions,...
FDA Approval Expected Monday of Ketamine-derived “Spravato”
TAKE HOME POINTS: SpravatoTM, a form of ketamine, will be FDA approved on Monday for Treatment Resistant Depression and for Major Depression with suicidality. FDA approval will result in insurance coverage for this form of ketamine, for this purpose, which will make it affordable for millions of suffering patients. Although it is...
End The Stigma!
Lady Gaga and Bradley Cooper did a masterful remake of “A Star is Born”, now in theaters. We highly recommend it! The issues of mental health and drug addiction are more timely than ever. Also, see Lady Gaga’s op-ed at lady-gaga-op-ed-on-suicide-and-mental-health. END THE STIGMA!
The Resurgence of Psychedelics in Medicine
There has been a flurry of articles in the media recently touting the successful use of psychedelics in medicine. Tim Ferriss, the New-York Times bestselling author, blogger, and angel investor, whose podcast has over 200 million downloads, recently interviewed Michael Pollan about his new book on the emerging science of psychedelics in what Ferriss dubbed...
Ketamine Infusions Provide Effective Relief for Severe Chronic Headache
Medical research is revealing more and more applications for ketamine, the old drug being used in new ways. Just as with Treatment Resistant Depression, where ketamine provides relief in 80% of patients, it is also often successful at relieving intractable headache pain. Indeed, the term “Treatment-Resistant Headache” could be used for the millions of women...